Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities
Journal of Clinical Medicine · 11.02.2025 · 14 (4) · 1190
DOI: 10.3390/jcm14041190 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.02.2025. Verfasst von Alexis G Dickerson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medici…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, National Institute of Health, USA.
Abstract (Originalsprache)
Preeclampsia (PE) is a major cause of maternal mortality and morbidity, affecting 3–6% of pregnancies worldwide and ranking among the top six causes of maternal deaths in the U.S. PE typically develops after 20 weeks of gestation and is characterized by new-onset hypertension and/or end-organ dysfunction, with or without proteinuria. Current management strategies for PE emphasize early diagnosis, blood pressure control, and timely delivery. For prevention, low-dose aspirin (81 mg/day) is recommended for high-risk women between 12 and 28 weeks of gestation. Magnesium sulfate is also advised to prevent seizures in preeclamptic women at risk of eclampsia. Emerging management approaches include antiangiogenic therapies, hypoxia-inducible factor suppression, statins, and supplementation with CoQ10, nitric oxide, and hydrogen sulfide donors. Black women are at particularly high risk for PE, potentially due to higher rates of hypertension and cholesterol, compounded by healthcare disparities and possible genetic factors, such as the APOL1 gene. This review explores current and emerging strategies for managing PE and addresses the underlying causes of health disparities, offering potential solutions to improve outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY 10031, USA.
- Department of Chemistry and Physics, State University of New York at Old Westbury, Old Westbury, NY 11568, USA.
- Graduate Program in Biology, City University of New York Graduate Center, New York, NY 10091, USA.
ORCID-Profile: Christiana A Joseph, Khosrow Kashfi
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
- National Institute of Health, USA
- National Institutes of Health, USA
Zitieren
APA
Dickerson, A. G., Joseph, C. A., & Kashfi, K. (2025). Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities. Journal of Clinical Medicine, 14(4), 1190. https://doi.org/10.3390/jcm14041190
Vancouver
Dickerson AG, Joseph CA, Kashfi K. Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities. Journal of Clinical Medicine. 2025;14(4):1190. doi:10.3390/jcm14041190
BibTeX
@article{Dickerson2025,
author = {Dickerson, Alexis G and Joseph, Christiana A and Kashfi, Khosrow},
title = {Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {4},
pages = {1190},
doi = {10.3390/jcm14041190}
}
EUVIMED